TrialBJU international2020

Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.

Sumanta K Pal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.